logo
ProjectForthcoming

Advancing Pharmacogenomics for Precision Medicine in Latvia

The status, timeline and source of this project. A free account opens every field.

Source: EU Funding & Tenders Portal

PGx4Latvia aims to strengthen pharmacogenomics (PGx) excellence and research capacity in Latvia, enabling the integration of precision medicine into the healthcare. Despite international progress, PGx application in Latvia remains fragmented, with limited testing availability and clinical uptake. The project addresses this gap through a strategic Twinning collaboration between the Latvian Biomedic

Status
Prospective
Sector
Hospital, Education
Location
Latvia, Netherlands, Estonia
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Advancing Pharmacogenomics for Precision Medicine in Latvia

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Advancing Pharmacogenomics for Precision Medicine in Latvia” is an infrastructure initiative in the Hospital sector, located in Latvia, Netherlands, Estonia. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

PGx4Latvia aims to strengthen pharmacogenomics (PGx) excellence and research capacity in Latvia, enabling the integration of precision medicine into the healthcare. Despite international progress, PGx application in Latvia remains fragmented, with limited testing availability and clinical uptake. The project addresses this gap through a strategic Twinning collaboration between the Latvian Biomedical Research and Study Centre, the University of Latvia, Leiden University Medical Center, and the University of Tartu. The project pursues five objectives. First, to elevate research excellence, a PGx clinical pilot will be implemented by analysing Latvian genomic and prescription data, identifying actionable drug-gene pairs, and developing a workflow for PGx-guided prescribing. Second, to establish a scientific network, knowledge transfer will occur via staff exchanges, joint seminars and participation in international PGx consortia, ensuring alignment with global standards. Third, to increase visibility and policy impact, PGx4Latvia will engage stakeholders, update medical curricula, and develop a national PGx implementation strategy. Fourth, to strengthen research management, administrative staff will receive training in project management, ethics, and innovation translation through peer-learning with advanced institutions. Fifth, to foster innovation and brain circulation, the project will deliver training in multi-omics, drug-gene interactions, and organise workshops and an international conference. These objectives will be achieved through integrated work packages combining research, training, mobility, and dissemination, with outputs including publications and collaborations. PGx4Latvia aligns with Horizon Europe Widening by strengthening excellence, partnerships, and research capacity. It contributes to EU priorities by advancing personalised medicine, integrating Latvian genomic data into the European Research Area, and supporting sustainable healthcare innovation.

Location

Country

Latvia, Netherlands, Estonia

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Hospital, Education

Article published date

2026-11-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project